<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00614107</url>
  </required_header>
  <id_info>
    <org_study_id>5301UMU</org_study_id>
    <nct_id>NCT00614107</nct_id>
  </id_info>
  <brief_title>Organization in Acute Atrial Fibrillation Post Open Heart Surgery</brief_title>
  <acronym>A-Fib</acronym>
  <official_title>Organization in Acute Atrial Fibrillation Post Open Heart Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>State University of New York - Upstate Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>State University of New York - Upstate Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A form of irregular heart rate called, Atrial Fibrillation (AF) is a major clinical problem.&#xD;
      It afflicts about 2 million Americans and is the single largest heart related cause of&#xD;
      stroke. However, despite 120 years of speculation and research, the mechanisms that cause AF&#xD;
      are poorly understood. Acute AF is also the most common irregular heart rate after open-heart&#xD;
      surgery in patients. This is seen in as many as 30% of such patients and often results in a&#xD;
      longer hospital stay.&#xD;
&#xD;
      In this study we would like to study the pattern of atrial fibrosis (scar tissue in the&#xD;
      heart) and an associated blood marker (a protein called pro-collagen-1) in those patients&#xD;
      concurrently having open heart surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">January 2009</completion_date>
  <primary_completion_date type="Actual">January 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">75</enrollment>
  <condition>Atrial Fibrillation</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Tissue sample for the right and left sid eof the heart.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Any person over 18 years having an elective valve, CABG or combination procedure&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. 18 years of age, Male or Female&#xD;
&#xD;
          2. Able to provide consent&#xD;
&#xD;
          3. Cardiac surgery, CABG of Valve replacement or repair.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. If AF terminates within 1 hour of initiation.&#xD;
&#xD;
          2. If the patient undergoes electrical cardioversion and/or receives digitalis within the&#xD;
             first hour of inclusion.&#xD;
&#xD;
          3. If the patients and/or their family or the primary caregiver choose to be excluded&#xD;
             from the study anytime, even after the initial 24-hour period.&#xD;
&#xD;
          4. If the patient expires within 1 hour of inclusion into the study. -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>SUNY Upstate Medical University</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2008</verification_date>
  <study_first_submitted>January 30, 2008</study_first_submitted>
  <study_first_submitted_qc>February 12, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 13, 2008</study_first_posted>
  <last_update_submitted>October 19, 2021</last_update_submitted>
  <last_update_submitted_qc>October 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2021</last_update_posted>
  <responsible_party>
    <name_title>Gregory Fink</name_title>
    <organization>SUNY Upstate Medical UNiversity</organization>
  </responsible_party>
  <keyword>Atrial Fibrillation post open heart surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

